retatrutide glp-1 gip glucagon receptor agonist The TRIUMPH-1 Phase 3 results just dropped on retatrutide. Here is what the numbers actually say. is a triple agonist. It targets GLP-1, GIP, and receptors. Ozempic targets one. Mounjaro The power of three: Retatrutide's

Your body maintains a delicate balance between copper and zinc

Without enough vitamin B12 in ones daily diet, hair follicles might not receive the oxygen and nutrients they need to grow thicker hair

Why This Matters Peptides have exploded in popularity across the wellness, biohacking, and sports medicine communities

Check every supplement with your clinic before stimulation starts

Biochemical studies have reported co-immunoprecipitation of JH1 and JH2 of JAK2, and that the pseudokinase acts to inhibit the kinase activity of JAKs (60, 79, 82)

Review the evidence on hepatotoxicity, ALT/AST levels, and safe dosing protocols